Feb 10, 2022 / 10:30AM GMT
Operator
Ladies and gentlemen, good day, and welcome to Alembic Pharmaceuticals ltd. Q3 FY '22 Financial Results Conference Call. (Operator Instructions)
I would now like to hand the conference over to Mr. RJ Baheti, Director Finance and CFO; Alembic Pharmaceuticals Ltd. Thank you, and over to you, sir.
Raj Kumar Shreeram Baheti - Alembic Pharmaceuticals Limited - Director of Finance, CFO & Executive Director
Thank you. Good afternoon, friends. Thank you for joining the third quarter results conference call. I'm sure most of you would have received our results by now. However, let me take you through the numbers for the quarter and 9 months ended 31st December 2021.
During the quarter, our total revenue down by 3% to INR 1,272 crores. EBITDA was INR 269 crores, which is 21% of sales. Profit before tax and profit after tax is INR 209 crores and INR 176 crores, respectively. EPS for the quarter is INR 8.9 per share versus INR 14.88 per share in the corresponding quarter in the previous year. As I explained in the previous quarter's call, the
Q3 2022 Alembic Pharmaceuticals Ltd Earnings Call Transcript
Feb 10, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers